| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| TOR Serine-Threonine Kinases | 52 | 2018 | 2109 | 6.090 |
Why?
|
| Multiprotein Complexes | 33 | 2017 | 1119 | 5.230 |
Why?
|
| Proto-Oncogene Proteins c-akt | 22 | 2021 | 2503 | 2.980 |
Why?
|
| Tumor Suppressor Proteins | 31 | 2022 | 2849 | 2.760 |
Why?
|
| Tuberous Sclerosis | 15 | 2022 | 1029 | 2.170 |
Why?
|
| Signal Transduction | 50 | 2021 | 23403 | 2.140 |
Why?
|
| Activating Transcription Factor 4 | 4 | 2021 | 80 | 1.820 |
Why?
|
| Lysosomes | 5 | 2022 | 893 | 1.480 |
Why?
|
| Phosphatidylinositol 3-Kinases | 13 | 2019 | 2938 | 1.390 |
Why?
|
| Protein Kinases | 14 | 2009 | 1640 | 1.350 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 3 | 2017 | 27 | 1.240 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 4 | 2015 | 137 | 1.100 |
Why?
|
| Protein Biosynthesis | 7 | 2017 | 2126 | 1.090 |
Why?
|
| Proteins | 17 | 2016 | 6103 | 1.090 |
Why?
|
| Metabolism | 2 | 2019 | 196 | 0.950 |
Why?
|
| Ribosomal Protein S6 Kinases | 7 | 2013 | 205 | 0.880 |
Why?
|
| Purine Nucleotides | 2 | 2022 | 28 | 0.840 |
Why?
|
| IMP Dehydrogenase | 1 | 2020 | 34 | 0.740 |
Why?
|
| Ribonucleosides | 1 | 2020 | 82 | 0.720 |
Why?
|
| Transcription Factors | 15 | 2014 | 12208 | 0.710 |
Why?
|
| Sirolimus | 10 | 2017 | 1564 | 0.690 |
Why?
|
| Serine | 2 | 2022 | 826 | 0.670 |
Why?
|
| Glutathione | 2 | 2021 | 589 | 0.660 |
Why?
|
| Nuclear Respiratory Factor 1 | 2 | 2015 | 23 | 0.660 |
Why?
|
| AMP-Activated Protein Kinases | 6 | 2017 | 611 | 0.650 |
Why?
|
| Neoplasms | 17 | 2019 | 21683 | 0.640 |
Why?
|
| Energy Metabolism | 5 | 2019 | 2899 | 0.640 |
Why?
|
| NADP | 1 | 2019 | 226 | 0.630 |
Why?
|
| Amino Acids | 6 | 2022 | 1736 | 0.620 |
Why?
|
| Mycophenolic Acid | 1 | 2020 | 343 | 0.620 |
Why?
|
| Animals | 68 | 2022 | 168757 | 0.620 |
Why?
|
| Drug Resistance, Fungal | 1 | 2017 | 52 | 0.610 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2022 | 2915 | 0.610 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 2 | 2015 | 52 | 0.610 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2017 | 4554 | 0.600 |
Why?
|
| Insulin | 10 | 2021 | 6580 | 0.600 |
Why?
|
| Nucleotides | 2 | 2017 | 464 | 0.590 |
Why?
|
| Liver | 6 | 2021 | 7474 | 0.570 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2019 | 437 | 0.570 |
Why?
|
| Phosphorylation | 17 | 2019 | 8436 | 0.560 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2019 | 783 | 0.550 |
Why?
|
| Fatty Acids | 2 | 2022 | 1809 | 0.550 |
Why?
|
| Mice | 45 | 2022 | 81183 | 0.550 |
Why?
|
| Lipogenesis | 2 | 2015 | 212 | 0.540 |
Why?
|
| Glycolysis | 4 | 2021 | 827 | 0.540 |
Why?
|
| Tetrahydrofolates | 1 | 2016 | 61 | 0.530 |
Why?
|
| Genes, Tumor Suppressor | 7 | 2017 | 1097 | 0.530 |
Why?
|
| Oncogene Proteins | 1 | 2019 | 749 | 0.520 |
Why?
|
| GTPase-Activating Proteins | 5 | 2022 | 498 | 0.520 |
Why?
|
| Glucose | 6 | 2021 | 4397 | 0.500 |
Why?
|
| Lipid Metabolism | 3 | 2015 | 1889 | 0.490 |
Why?
|
| HeLa Cells | 7 | 2017 | 3128 | 0.480 |
Why?
|
| Lipids | 3 | 2016 | 3305 | 0.470 |
Why?
|
| Giant Cells | 1 | 2014 | 187 | 0.470 |
Why?
|
| Mice, Knockout | 15 | 2022 | 14557 | 0.470 |
Why?
|
| Elongation Factor 2 Kinase | 1 | 2013 | 10 | 0.470 |
Why?
|
| Purines | 2 | 2022 | 594 | 0.470 |
Why?
|
| Cell Division | 5 | 2009 | 4568 | 0.460 |
Why?
|
| Peptide Chain Elongation, Translational | 1 | 2013 | 33 | 0.460 |
Why?
|
| Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) | 1 | 2013 | 11 | 0.450 |
Why?
|
| Dihydroorotase | 1 | 2013 | 11 | 0.450 |
Why?
|
| Aspartate Carbamoyltransferase | 1 | 2013 | 22 | 0.450 |
Why?
|
| Repressor Proteins | 8 | 2005 | 3023 | 0.450 |
Why?
|
| Monomeric GTP-Binding Proteins | 5 | 2012 | 199 | 0.450 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 2 | 2010 | 56 | 0.440 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 3 | 2017 | 104 | 0.440 |
Why?
|
| Models, Biological | 10 | 2012 | 9583 | 0.420 |
Why?
|
| Carrier Proteins | 6 | 2012 | 5021 | 0.420 |
Why?
|
| Metformin | 2 | 2017 | 835 | 0.410 |
Why?
|
| Enzyme Inhibitors | 2 | 2020 | 3798 | 0.410 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2015 | 1338 | 0.410 |
Why?
|
| Microtubule Proteins | 3 | 2000 | 61 | 0.400 |
Why?
|
| Hepatocytes | 3 | 2017 | 1211 | 0.400 |
Why?
|
| Saccharomyces cerevisiae | 5 | 2017 | 2752 | 0.400 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2016 | 871 | 0.380 |
Why?
|
| Cell Line, Tumor | 14 | 2021 | 16689 | 0.370 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2010 | 124 | 0.360 |
Why?
|
| Immunoblotting | 5 | 2017 | 1682 | 0.360 |
Why?
|
| Feedback, Physiological | 3 | 2011 | 479 | 0.350 |
Why?
|
| Monoacylglycerol Lipases | 1 | 2010 | 48 | 0.350 |
Why?
|
| Cell Proliferation | 12 | 2021 | 10481 | 0.340 |
Why?
|
| RNA Interference | 7 | 2018 | 2889 | 0.340 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2015 | 1692 | 0.340 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2011 | 370 | 0.330 |
Why?
|
| Neuropeptides | 5 | 2012 | 942 | 0.330 |
Why?
|
| Adipocytes | 3 | 2012 | 1184 | 0.320 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2009 | 195 | 0.320 |
Why?
|
| Cell Line | 11 | 2021 | 15997 | 0.320 |
Why?
|
| Caenorhabditis elegans | 2 | 2016 | 1419 | 0.320 |
Why?
|
| Glioblastoma | 2 | 2021 | 3481 | 0.310 |
Why?
|
| Neoplasm Proteins | 1 | 2020 | 3703 | 0.300 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 399 | 0.300 |
Why?
|
| Analgesics | 1 | 2013 | 1040 | 0.280 |
Why?
|
| Humans | 72 | 2021 | 744343 | 0.280 |
Why?
|
| Fibroblasts | 7 | 2021 | 4161 | 0.280 |
Why?
|
| Mice, Inbred C57BL | 12 | 2021 | 21827 | 0.270 |
Why?
|
| Mitochondria | 3 | 2016 | 3520 | 0.270 |
Why?
|
| Transcription, Genetic | 4 | 2016 | 7722 | 0.270 |
Why?
|
| Myocardium | 1 | 2019 | 4776 | 0.270 |
Why?
|
| Homeostasis | 4 | 2016 | 3340 | 0.260 |
Why?
|
| Heart | 1 | 2019 | 4467 | 0.260 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 430 | 0.250 |
Why?
|
| Chromatography, Liquid | 3 | 2019 | 976 | 0.240 |
Why?
|
| HEK293 Cells | 4 | 2019 | 4204 | 0.230 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2219 | 0.220 |
Why?
|
| Saccharomyces cerevisiae Proteins | 4 | 2000 | 1888 | 0.220 |
Why?
|
| Neurons | 2 | 2022 | 9338 | 0.220 |
Why?
|
| 3T3-L1 Cells | 3 | 2013 | 198 | 0.210 |
Why?
|
| Gene Expression Regulation | 4 | 2019 | 12072 | 0.210 |
Why?
|
| Phosphotransferases | 1 | 2002 | 308 | 0.200 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2006 | 1213 | 0.200 |
Why?
|
| Feedback | 1 | 2005 | 795 | 0.200 |
Why?
|
| Animal Feed | 1 | 2021 | 110 | 0.200 |
Why?
|
| Fungal Proteins | 3 | 2000 | 912 | 0.190 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 3 | 2018 | 627 | 0.190 |
Why?
|
| Pyrimidines | 1 | 2013 | 2942 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 3 | 2000 | 1086 | 0.190 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2019 | 8428 | 0.190 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 232 | 0.180 |
Why?
|
| Antibiotics, Antineoplastic | 4 | 2015 | 692 | 0.180 |
Why?
|
| Molecular Motor Proteins | 1 | 2000 | 107 | 0.180 |
Why?
|
| Genetic Techniques | 1 | 2002 | 435 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 2214 | 0.170 |
Why?
|
| Gene Knockdown Techniques | 3 | 2015 | 1655 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2013 | 5172 | 0.170 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 9734 | 0.170 |
Why?
|
| HCT116 Cells | 2 | 2017 | 408 | 0.170 |
Why?
|
| Phospholipids | 1 | 2022 | 784 | 0.170 |
Why?
|
| Nitrogen Isotopes | 1 | 2019 | 84 | 0.170 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2013 | 2916 | 0.160 |
Why?
|
| Amino Acids, Sulfur | 1 | 2018 | 16 | 0.160 |
Why?
|
| Amino Acid Sequence | 6 | 2012 | 13815 | 0.160 |
Why?
|
| Phosphoribosylglycinamide Formyltransferase | 1 | 2017 | 3 | 0.160 |
Why?
|
| Food | 2 | 2013 | 771 | 0.160 |
Why?
|
| Carbon Isotopes | 1 | 2019 | 467 | 0.160 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 2017 | 11 | 0.160 |
Why?
|
| Thymidylate Synthase | 1 | 2017 | 75 | 0.150 |
Why?
|
| Genes, Lethal | 1 | 2017 | 242 | 0.150 |
Why?
|
| Isotope Labeling | 1 | 2019 | 406 | 0.150 |
Why?
|
| Cells, Cultured | 9 | 2019 | 19229 | 0.150 |
Why?
|
| Cell Cycle | 4 | 2017 | 2967 | 0.150 |
Why?
|
| Hydrogen Sulfide | 1 | 2018 | 137 | 0.140 |
Why?
|
| Polyamines | 1 | 2017 | 120 | 0.140 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 2015 | 0.140 |
Why?
|
| RNA, Ribosomal | 1 | 2017 | 246 | 0.140 |
Why?
|
| Methenyltetrahydrofolate Cyclohydrolase | 1 | 2016 | 9 | 0.140 |
Why?
|
| Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2016 | 17 | 0.140 |
Why?
|
| Oxidoreductases Acting on CH-CH Group Donors | 1 | 2017 | 167 | 0.140 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2016 | 26 | 0.140 |
Why?
|
| Tumor Cells, Cultured | 5 | 2017 | 6314 | 0.140 |
Why?
|
| Fasting | 1 | 2022 | 1593 | 0.140 |
Why?
|
| Liver Neoplasms | 1 | 2012 | 4253 | 0.140 |
Why?
|
| Substrate Specificity | 3 | 2007 | 1801 | 0.140 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2019 | 1157 | 0.140 |
Why?
|
| rho GTP-Binding Proteins | 1 | 1997 | 293 | 0.130 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 18111 | 0.130 |
Why?
|
| Glutamine | 1 | 2019 | 578 | 0.130 |
Why?
|
| Cytosol | 1 | 2019 | 901 | 0.130 |
Why?
|
| Pressure | 1 | 2019 | 1203 | 0.130 |
Why?
|
| Autophagy | 2 | 2014 | 1300 | 0.130 |
Why?
|
| Lysophosphatidylcholines | 1 | 2015 | 81 | 0.130 |
Why?
|
| Brain | 1 | 2022 | 26385 | 0.130 |
Why?
|
| Epistasis, Genetic | 1 | 2017 | 365 | 0.130 |
Why?
|
| Class III Phosphatidylinositol 3-Kinases | 1 | 2014 | 18 | 0.130 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 730 | 0.130 |
Why?
|
| Eukaryotic Initiation Factor-2 | 1 | 2016 | 190 | 0.130 |
Why?
|
| Embryo, Mammalian | 1 | 2021 | 1701 | 0.130 |
Why?
|
| Triglycerides | 1 | 2022 | 2454 | 0.130 |
Why?
|
| Glutarates | 1 | 2016 | 236 | 0.120 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 5853 | 0.120 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2014 | 59 | 0.120 |
Why?
|
| Cytoskeletal Proteins | 1 | 2000 | 1364 | 0.120 |
Why?
|
| RNA, Small Interfering | 5 | 2018 | 3505 | 0.120 |
Why?
|
| Caloric Restriction | 1 | 2016 | 302 | 0.120 |
Why?
|
| PTEN Phosphohydrolase | 4 | 2017 | 1142 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 2187 | 0.120 |
Why?
|
| Drug Therapy | 1 | 2017 | 497 | 0.120 |
Why?
|
| Nucleoside-Phosphate Kinase | 1 | 2013 | 23 | 0.120 |
Why?
|
| Cell Polarity | 2 | 2013 | 645 | 0.120 |
Why?
|
| GTP-Binding Proteins | 1 | 1997 | 970 | 0.110 |
Why?
|
| Lymphangioleiomyomatosis | 1 | 2015 | 210 | 0.110 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 1878 | 0.110 |
Why?
|
| Hamartoma | 2 | 2005 | 238 | 0.110 |
Why?
|
| Macrophage Activation | 1 | 2016 | 558 | 0.110 |
Why?
|
| Thiolester Hydrolases | 1 | 2013 | 86 | 0.110 |
Why?
|
| Fluorouracil | 1 | 2017 | 1619 | 0.110 |
Why?
|
| Phospholipid Transfer Proteins | 1 | 2013 | 91 | 0.110 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 1782 | 0.110 |
Why?
|
| Biosynthetic Pathways | 1 | 2013 | 137 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 1997 | 1185 | 0.110 |
Why?
|
| Isoenzymes | 1 | 2017 | 1726 | 0.100 |
Why?
|
| Mice, SCID | 1 | 2017 | 2716 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2016 | 907 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2005 | 431 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2017 | 2008 | 0.100 |
Why?
|
| Ferritins | 1 | 2014 | 590 | 0.100 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2009 | 1676 | 0.100 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2012 | 285 | 0.100 |
Why?
|
| Benzoquinones | 1 | 2011 | 201 | 0.100 |
Why?
|
| Methotrexate | 1 | 2017 | 1727 | 0.100 |
Why?
|
| Binding Sites | 3 | 2009 | 6114 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2014 | 509 | 0.090 |
Why?
|
| PPAR gamma | 2 | 2013 | 493 | 0.090 |
Why?
|
| Drosophila | 1 | 2017 | 1491 | 0.090 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 852 | 0.090 |
Why?
|
| Molecular Targeted Therapy | 3 | 2017 | 2727 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 190 | 0.090 |
Why?
|
| Phosphothreonine | 1 | 2009 | 63 | 0.090 |
Why?
|
| Drosophila Proteins | 2 | 2017 | 1703 | 0.090 |
Why?
|
| Seizures | 1 | 2022 | 2859 | 0.090 |
Why?
|
| Lactams, Macrocyclic | 1 | 2011 | 320 | 0.090 |
Why?
|
| Light | 1 | 2016 | 1374 | 0.090 |
Why?
|
| Macrophages | 2 | 2016 | 5655 | 0.090 |
Why?
|
| Metabolomics | 3 | 2017 | 1484 | 0.090 |
Why?
|
| Phosphoserine | 1 | 2009 | 206 | 0.090 |
Why?
|
| Protein Kinase C-alpha | 1 | 2009 | 112 | 0.080 |
Why?
|
| Adipogenesis | 1 | 2012 | 359 | 0.080 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 898 | 0.080 |
Why?
|
| Longevity | 1 | 2016 | 1070 | 0.080 |
Why?
|
| Feeding Behavior | 1 | 2021 | 3188 | 0.080 |
Why?
|
| Immunohistochemistry | 3 | 2012 | 11366 | 0.080 |
Why?
|
| 14-3-3 Proteins | 1 | 2009 | 214 | 0.080 |
Why?
|
| Vertebrates | 1 | 2009 | 227 | 0.080 |
Why?
|
| Insulin Resistance | 4 | 2014 | 3864 | 0.080 |
Why?
|
| Neurofibromin 2 | 1 | 2009 | 267 | 0.080 |
Why?
|
| Lymph Nodes | 1 | 2019 | 3474 | 0.080 |
Why?
|
| Cell Survival | 4 | 2019 | 5882 | 0.080 |
Why?
|
| Angiomyolipoma | 1 | 2009 | 190 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2009 | 337 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2014 | 1026 | 0.080 |
Why?
|
| Cell Enlargement | 1 | 2007 | 61 | 0.080 |
Why?
|
| Boronic Acids | 1 | 2012 | 965 | 0.080 |
Why?
|
| Mutation | 5 | 2017 | 29786 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 249 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2018 | 3508 | 0.070 |
Why?
|
| Cell Cycle Proteins | 3 | 2015 | 3462 | 0.070 |
Why?
|
| Mass Spectrometry | 2 | 2015 | 2203 | 0.070 |
Why?
|
| Protein Binding | 3 | 2014 | 9386 | 0.070 |
Why?
|
| Immediate-Early Proteins | 1 | 2009 | 453 | 0.070 |
Why?
|
| Models, Animal | 2 | 2011 | 2171 | 0.070 |
Why?
|
| Iron | 1 | 2014 | 1774 | 0.070 |
Why?
|
| ras Proteins | 1 | 2011 | 1060 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 2 | 2018 | 1351 | 0.070 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 4479 | 0.070 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1202 | 0.070 |
Why?
|
| Pyrazines | 1 | 2012 | 1230 | 0.070 |
Why?
|
| Muscles | 1 | 2011 | 1614 | 0.070 |
Why?
|
| Esophageal Diseases | 1 | 2006 | 166 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2015 | 3748 | 0.060 |
Why?
|
| Hypothalamus | 1 | 2011 | 1063 | 0.060 |
Why?
|
| Multienzyme Complexes | 2 | 2008 | 686 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2009 | 1791 | 0.060 |
Why?
|
| Herpesvirus 8, Human | 1 | 2006 | 258 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 10943 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 2004 | 1101 | 0.060 |
Why?
|
| Pancreas | 1 | 2011 | 1686 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2017 | 3701 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2009 | 5179 | 0.060 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2013 | 5221 | 0.060 |
Why?
|
| Sequence Alignment | 1 | 2008 | 2256 | 0.060 |
Why?
|
| RNA, Messenger | 2 | 2009 | 13033 | 0.060 |
Why?
|
| Cell Size | 1 | 2005 | 643 | 0.060 |
Why?
|
| Protein Footprinting | 1 | 2002 | 10 | 0.060 |
Why?
|
| Receptors, Chemokine | 1 | 2006 | 669 | 0.060 |
Why?
|
| DNA Footprinting | 1 | 2002 | 98 | 0.060 |
Why?
|
| Energy Intake | 1 | 2011 | 2148 | 0.050 |
Why?
|
| Molecular Weight | 2 | 2002 | 2255 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2011 | 2499 | 0.050 |
Why?
|
| Cell Movement | 2 | 2022 | 5217 | 0.050 |
Why?
|
| Male | 9 | 2018 | 350118 | 0.050 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 464 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3752 | 0.050 |
Why?
|
| Pheromones | 2 | 2000 | 98 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2019 | 5181 | 0.050 |
Why?
|
| Interleukin-4 | 2 | 2016 | 1147 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 6171 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2016 | 3309 | 0.050 |
Why?
|
| Leptin | 1 | 2008 | 1599 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 10180 | 0.040 |
Why?
|
| Carbon Cycle | 1 | 2019 | 18 | 0.040 |
Why?
|
| eIF-2 Kinase | 2 | 2011 | 149 | 0.040 |
Why?
|
| Viral Proteins | 1 | 2006 | 1900 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2011 | 3279 | 0.040 |
Why?
|
| DNA-Binding Proteins | 2 | 2014 | 9648 | 0.040 |
Why?
|
| Cystathionine gamma-Lyase | 1 | 2018 | 36 | 0.040 |
Why?
|
| Carbon | 1 | 2022 | 687 | 0.040 |
Why?
|
| Genomics | 2 | 2013 | 5720 | 0.040 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 814 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2004 | 658 | 0.040 |
Why?
|
| Genes, Fungal | 1 | 1999 | 455 | 0.040 |
Why?
|
| Ischemia | 2 | 2018 | 1907 | 0.040 |
Why?
|
| K562 Cells | 1 | 2019 | 634 | 0.040 |
Why?
|
| Burkholderia cepacia | 1 | 1996 | 22 | 0.040 |
Why?
|
| Genes, Essential | 1 | 2017 | 183 | 0.040 |
Why?
|
| Kidney Neoplasms | 2 | 2012 | 4262 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2006 | 2942 | 0.030 |
Why?
|
| S-Adenosylmethionine | 1 | 2017 | 212 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2019 | 1369 | 0.030 |
Why?
|
| RNA Precursors | 1 | 2016 | 208 | 0.030 |
Why?
|
| Protein Stability | 1 | 2017 | 557 | 0.030 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 203 | 0.030 |
Why?
|
| Disease Progression | 1 | 2012 | 13284 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2019 | 635 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2019 | 1572 | 0.030 |
Why?
|
| Naphthyridines | 1 | 2015 | 118 | 0.030 |
Why?
|
| Amino Acids, Essential | 1 | 2014 | 24 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1999 | 2839 | 0.030 |
Why?
|
| DNA Primers | 1 | 1999 | 2892 | 0.030 |
Why?
|
| Physical Conditioning, Animal | 1 | 2018 | 362 | 0.030 |
Why?
|
| Gene Deletion | 1 | 2002 | 2751 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2017 | 11124 | 0.030 |
Why?
|
| Diet, Protein-Restricted | 1 | 2014 | 71 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2011 | 7880 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14722 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2003 | 2455 | 0.030 |
Why?
|
| Endoplasmic Reticulum | 2 | 2011 | 1144 | 0.030 |
Why?
|
| Thymine Nucleotides | 1 | 2013 | 63 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2014 | 386 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2006 | 3479 | 0.030 |
Why?
|
| Phagosomes | 1 | 2014 | 193 | 0.030 |
Why?
|
| Chitin | 1 | 2013 | 41 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1085 | 0.030 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1348 | 0.030 |
Why?
|
| STAT6 Transcription Factor | 1 | 2013 | 199 | 0.030 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2013 | 459 | 0.030 |
Why?
|
| Disease Models, Animal | 3 | 2018 | 18029 | 0.030 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2014 | 876 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2014 | 481 | 0.030 |
Why?
|
| Apoptosis | 1 | 2008 | 9727 | 0.030 |
Why?
|
| Genome, Bacterial | 1 | 1996 | 760 | 0.030 |
Why?
|
| Microtubules | 1 | 1997 | 1090 | 0.020 |
Why?
|
| Chemokines | 1 | 2016 | 970 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2014 | 809 | 0.020 |
Why?
|
| Antineoplastic Agents | 2 | 2011 | 13695 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 11524 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2132 | 0.020 |
Why?
|
| Goals | 1 | 2016 | 706 | 0.020 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2012 | 186 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2011 | 643 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2011 | 8863 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2019 | 3200 | 0.020 |
Why?
|
| Arachnoid | 1 | 2009 | 48 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2017 | 1708 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 13102 | 0.020 |
Why?
|
| Oxidative Stress | 2 | 2011 | 3086 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2011 | 434 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 5524 | 0.020 |
Why?
|
| Transfection | 2 | 2009 | 5892 | 0.020 |
Why?
|
| Genome | 1 | 2016 | 1808 | 0.020 |
Why?
|
| Obesity | 1 | 2010 | 12745 | 0.020 |
Why?
|
| Phenylbutyrates | 1 | 2008 | 69 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2011 | 2948 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2016 | 1990 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 1706 | 0.020 |
Why?
|
| Base Sequence | 1 | 1999 | 12797 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2013 | 944 | 0.020 |
Why?
|
| Adaptation, Physiological | 1 | 2014 | 1312 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 2505 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2014 | 1403 | 0.020 |
Why?
|
| Peptides | 1 | 1999 | 4409 | 0.020 |
Why?
|
| Oncogene Protein v-akt | 1 | 2006 | 135 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3647 | 0.020 |
Why?
|
| DNA Replication | 1 | 2013 | 1399 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2015 | 1708 | 0.020 |
Why?
|
| Rupture, Spontaneous | 1 | 2006 | 354 | 0.020 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2008 | 563 | 0.020 |
Why?
|
| Histones | 1 | 2016 | 2599 | 0.020 |
Why?
|
| Cisplatin | 1 | 2011 | 1662 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 2216 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2006 | 277 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6386 | 0.020 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 2004 | 50 | 0.020 |
Why?
|
| Female | 5 | 2018 | 380194 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2003 | 2440 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2011 | 2077 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1889 | 0.010 |
Why?
|
| Neurilemmoma | 1 | 2009 | 547 | 0.010 |
Why?
|
| Sarcoma, Kaposi | 1 | 2006 | 370 | 0.010 |
Why?
|
| DNA Damage | 1 | 2013 | 2432 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 5867 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2013 | 3494 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 829 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2019 | 11483 | 0.010 |
Why?
|
| Phenotype | 1 | 1999 | 16365 | 0.010 |
Why?
|
| Body Weight | 1 | 2012 | 4669 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1801 | 0.010 |
Why?
|
| Chemical Fractionation | 1 | 2000 | 65 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4665 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 1 | 2000 | 313 | 0.010 |
Why?
|
| Meningioma | 1 | 2009 | 1209 | 0.010 |
Why?
|
| Syndrome | 1 | 2006 | 3251 | 0.010 |
Why?
|
| Biological Assay | 1 | 2003 | 652 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2003 | 1723 | 0.010 |
Why?
|
| Sucrose | 1 | 2000 | 164 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2006 | 3689 | 0.010 |
Why?
|
| Protein Interaction Mapping | 1 | 2003 | 627 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 2000 | 256 | 0.010 |
Why?
|
| Colonic Polyps | 1 | 2004 | 542 | 0.010 |
Why?
|
| Rats | 1 | 2015 | 24260 | 0.010 |
Why?
|
| Dimerization | 1 | 2000 | 893 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2009 | 5974 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2005 | 35421 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 1276 | 0.010 |
Why?
|
| Plasmids | 1 | 2003 | 2307 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 2025 | 0.010 |
Why?
|
| Aging | 1 | 2016 | 8664 | 0.010 |
Why?
|
| Replicon | 1 | 1996 | 34 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 3002 | 0.010 |
Why?
|
| Point Mutation | 1 | 2002 | 1623 | 0.010 |
Why?
|
| Pseudomonas | 1 | 1996 | 117 | 0.010 |
Why?
|
| Biodegradation, Environmental | 1 | 1996 | 219 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 1996 | 290 | 0.010 |
Why?
|
| Chromosomes, Bacterial | 1 | 1996 | 282 | 0.010 |
Why?
|
| RNA, Bacterial | 1 | 1996 | 390 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2000 | 3846 | 0.010 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 1996 | 954 | 0.010 |
Why?
|
| DNA Transposable Elements | 1 | 1996 | 748 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1996 | 1079 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 1465 | 0.010 |
Why?
|
| Phylogeny | 1 | 1996 | 2803 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1996 | 4740 | 0.000 |
Why?
|
| United States | 1 | 2016 | 69872 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2008 | 41006 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2012 | 63114 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2006 | 57776 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2006 | 77449 | 0.000 |
Why?
|
| Aged | 1 | 2006 | 163280 | 0.000 |
Why?
|
| Middle Aged | 1 | 2006 | 213383 | 0.000 |
Why?
|
| Adult | 1 | 2006 | 214055 | 0.000 |
Why?
|